在心肌细胞中亚细胞铁摄取缺陷的替代机制
Yuanyuan Dai1,2, Nadezda Ignatyeva1,2, Hang Xu1,2
1Heart Research Center Goettingen, Clinic for Cardiology and Pneumology, University Medical Center Goettingen, Georg-August University of Goettingen, Germany (Y.D., N.I., H.X., R.W., K.T., S.B., S.S., E.M.Z., S.E.L., G.H., A.E.).
Circulation research
|June 14, 2023
概括
心力衰竭患者通常由于细胞铁吸收受损而缺乏铁. 这项研究揭示了心脏细胞中缺陷的内细胞形成,为心力衰竭中的铁缺乏提供了新的治疗点.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 系统性铁缺乏症影响50%的心力衰竭患者.
- 细胞下铁吸收缺陷,独立于系统吸收,尚未完全理解.
- 克拉特林介导的内细胞分裂是心肌细胞中主要的细胞内铁吸收途径.
研究的目的:
- 为了研究心力衰竭中细胞下铁吸收机制.
- 使用诱导多能干细胞 (iPSCs) 探索扩张性心肌病 (DCM) 中的分子功能障碍.
- 确定可用药物的途径,以治疗心力衰竭中的铁缺乏症.
主要方法:
- 使用患者衍生和CRISPR/Cas编辑的iPSC衍生心肌细胞.
- 采用基于质谱的蛋白质组学和信号通路分析.
- 研究了遗传DCM突变 (TnT-R141W,TPM1-L185F) 的遗传iPSC模型.
主要成果:
- 鉴定了克拉特林介导的受损内细胞和内体运输作为细胞下铁缺乏症的原因.
- 在iPSC衍生的心肌细胞和患有DCM的患者心脏组织中确认了内细胞分裂缺陷.
- 证明纠正突变或补充铁/Rho激活剂II可挽救疾病途径并改善收缩性.
结论:
- 导致细胞下铁缺乏的受损内细胞和货物运输是遗传DCM的一个关键机制.
- 这些发现为患有遗传突变的心力衰竭患者提供了潜在的治疗策略.
- 了解这些分子机制可以帮助开发新的治疗方法和风险管理方法.
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Electron Transport Chain: Complex III and IV
7.7K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
7.7K
Electron Transport Chain: Complex I and II
14.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.6K


